Omnicell Net Debt vs Common Stock Total Equity Analysis
OMCL Stock | USD 32.59 0.06 0.18% |
Omnicell financial indicator trend analysis is much more than just breaking down Omnicell prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Omnicell is a good investment. Please check the relationship between Omnicell Net Debt and its Common Stock Total Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.
Net Debt vs Common Stock Total Equity
Net Debt vs Common Stock Total Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Omnicell Net Debt account and Common Stock Total Equity. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Omnicell's Net Debt and Common Stock Total Equity is -0.08. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Common Stock Total Equity in the same time period over historical financial statements of Omnicell, assuming nothing else is changed. The correlation between historical values of Omnicell's Net Debt and Common Stock Total Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Omnicell are associated (or correlated) with its Common Stock Total Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Total Equity has no effect on the direction of Net Debt i.e., Omnicell's Net Debt and Common Stock Total Equity go up and down completely randomly.
Correlation Coefficient | -0.08 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.Most indicators from Omnicell's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Omnicell current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.At this time, Omnicell's Selling General Administrative is quite stable compared to the past year. Enterprise Value Over EBITDA is expected to rise to 34.21 this year, although the value of Tax Provision will most likely fall to (2.8 M).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 554.7M | 589.0M | 496.8M | 521.7M | Total Revenue | 1.1B | 1.3B | 1.1B | 1.2B |
Omnicell fundamental ratios Correlations
Click cells to compare fundamentals
Omnicell Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Omnicell fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.2B | 1.8B | 2.1B | 2.2B | 2.2B | 2.3B | |
Short Long Term Debt Total | 100.7M | 516.1M | 528.1M | 616.7M | 614.1M | 644.8M | |
Other Current Liab | 89.7M | 123.9M | 204.3M | 235.3M | 180.0M | 189.0M | |
Total Current Liabilities | 237.0M | 276.4M | 876.2M | 428.4M | 367.8M | 386.2M | |
Total Stockholder Equity | 845.3M | 967.5M | 1.1B | 1.1B | 1.2B | 1.2B | |
Other Liab | 57.9M | 64.5M | 79.7M | 46.2M | 53.1M | 33.7M | |
Property Plant And Equipment Net | 110.4M | 114.2M | 119.7M | 132.0M | 133.6M | 140.3M | |
Current Deferred Revenue | 90.9M | 100.1M | 112.2M | 118.9M | 132.3M | 138.9M | |
Net Debt | (26.5M) | 30.2M | 179.0M | 286.4M | 113.1M | 118.8M | |
Retained Earnings | 258.8M | 290.7M | 368.6M | 390.7M | 370.4M | 388.9M | |
Accounts Payable | 46.4M | 40.3M | 71.5M | 63.4M | 45.0M | 25.0M | |
Cash | 127.2M | 485.9M | 349.1M | 330.4M | 501.0M | 526.0M | |
Non Current Assets Total | 757.6M | 995.1M | 1.4B | 1.3B | 1.3B | 1.4B | |
Non Currrent Assets Other | 151.9M | 176.2M | 191.3M | 164.5M | 64.4M | 52.5M | |
Long Term Debt | 135.4M | 50M | 467.2M | 566.6M | 569.7M | 598.1M | |
Cash And Short Term Investments | 127.2M | 485.9M | 349.1M | 330.4M | 501.0M | 526.0M | |
Net Receivables | 218.4M | 190.1M | 240.9M | 299.5M | 263.9M | 277.1M | |
Common Stock Total Equity | 51K | 53K | 54K | 55K | 49.5K | 47.0K | |
Common Stock Shares Outstanding | 42.9M | 43.7M | 47.9M | 45.9M | 45.2M | 36.4M | |
Liabilities And Stockholders Equity | 1.2B | 1.8B | 2.1B | 2.2B | 2.2B | 2.3B | |
Non Current Liabilities Total | 158.6M | 580.6M | 119.6M | 652.2M | 670.1M | 703.6M | |
Inventory | 108.0M | 96.3M | 119.9M | 147.5M | 110.1M | 115.6M | |
Other Current Assets | 15.2M | 41.0M | 48.3M | 77.4M | 52.6M | 55.2M | |
Other Stockholder Equity | 595.9M | 682.3M | 786.5M | 756.4M | 832.0M | 873.6M | |
Total Liab | 395.6M | 857.0M | 995.8M | 1.1B | 1.0B | 1.1B | |
Property Plant And Equipment Gross | 110.4M | 114.2M | 119.7M | 132.0M | 273.0M | 286.7M | |
Total Current Assets | 483.2M | 829.4M | 780.7M | 881.8M | 927.6M | 973.9M | |
Accumulated Other Comprehensive Income | (9.4M) | (5.5M) | (8.4M) | (17.1M) | (13.4M) | (14.1M) | |
Short Term Debt | 10.1M | 12.2M | 488.2M | 10.8M | 10.5M | 10.0M | |
Common Stock | 51K | 53K | 54K | 55K | 56K | 53.2K | |
Property Plant Equipment | 54.2M | 59.1M | 119.7M | 94.0M | 108.1M | 113.5M | |
Other Assets | 100.7M | 268.5M | 225.6M | 139.0M | 159.8M | 167.8M | |
Good Will | 336.5M | 499.3M | 738.9M | 734.3M | 735.8M | 772.6M | |
Intangible Assets | 124.9M | 168.2M | 277.6M | 242.9M | 277.8M | 291.7M | |
Net Tangible Assets | 845.3M | 967.5M | 130.2M | 153.0M | 175.9M | 297.7M | |
Retained Earnings Total Equity | 258.8M | 290.7M | 368.6M | 390.7M | 449.3M | 471.8M | |
Capital Surpluse | 780.9M | 920.4M | 1.0B | 1.0B | 1.2B | 729.3M | |
Deferred Long Term Liab | 39.1M | 4.3M | 51.7M | 2.1M | 1.9M | 1.8M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Omnicell using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omnicell. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Omnicell Stock please use our How to buy in Omnicell Stock guide.Note that the Omnicell information on this page should be used as a complementary analysis to other Omnicell's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Complementary Tools for Omnicell Stock analysis
When running Omnicell's price analysis, check to measure Omnicell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omnicell is operating at the current time. Most of Omnicell's value examination focuses on studying past and present price action to predict the probability of Omnicell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omnicell's price. Additionally, you may evaluate how the addition of Omnicell to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Omnicell's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnicell. If investors know Omnicell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnicell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.68) | Earnings Share (0.46) | Revenue Per Share 24.275 | Quarterly Revenue Growth (0.15) | Return On Assets (0.01) |
The market value of Omnicell is measured differently than its book value, which is the value of Omnicell that is recorded on the company's balance sheet. Investors also form their own opinion of Omnicell's value that differs from its market value or its book value, called intrinsic value, which is Omnicell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnicell's market value can be influenced by many factors that don't directly affect Omnicell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnicell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnicell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnicell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.